SEC Tracker
Get the app

Hinge Health HNGE

Hinge Health names new president and director

Item 2.02 Reports results, Item 5.02 Executive or director change, Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Major
  1. James Pursley resigns as president effective Jan 1, 2027
  2. Pursley appointed as Class II director effective Jan 4, 2027
  3. Daniel Perez appointed president, continues as CEO
  4. Pursley to receive 40,000 RSUs (shares paid out over time) under advisor agreement

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Hinge Health files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

The reading, claim by claim

0 of 3 claims matched the filing text.

Not found in the filing text

  • For the quarter ended June 30, 2026, Hinge Health, Inc. reported revenue of $212.8 million and net income of $43.7 million.
  • The company's gross margin was 86.4%, operating margin 19.0%, and net margin 20.5% for the quarter.
  • Revenue increased by 53.0% compared to the same period a year earlier.

Similar companies

Companies of similar size in SIC 7374 and related industry codes: the same peer list as the financial tables.

  1. Rapid7 RPD public float $1.5B, Jun 30, 2025
  2. Innodata INOD public float $1.6B, Jun 30, 2025
  3. Appian APPN
  4. Certara CERT public float $1.4B, Jun 30, 2025
  5. Navan NAVN public float $1.4B, Mar 30, 2026